Human malignant melanomas express receptors for luteinizing hormone releasing hormone allowing targeted therapy with cytotoxic luteinizing hormone releasing hormone analogue.
about
A phenotypic high throughput screening assay for the identification of pharmacoperones for the gonadotropin releasing hormone receptorChaperoning G protein-coupled receptors: from cell biology to therapeuticsReceptor-targeting phthalocyanine photosensitizer for improving antitumor photocytotoxicity.Receptor-targeted therapy of human experimental urinary bladder cancers with cytotoxic LH-RH analog AN-152 [AEZS- 108]Melanoma in pregnancy: a case report and review of the literature.Substantial expression of luteinizing hormone-releasing hormone (LHRH) receptor type I in human uveal melanoma.Receptor-mediated tumor targeting based on peptide hormones.Novel LHRH-receptor-targeted cytolytic peptide, EP-100: first-in-human phase I study in patients with advanced LHRH-receptor-expressing solid tumors.Comparative in vitro biological evaluation of daunorubicin containing GnRH-I and GnRH-II conjugates developed for tumor targeting.An efficient chemical approach to bispecific antibodies and antibodies of high valencyConcurrence of chromosome 3 and 4 aberrations in human uveal melanoma.Characterization of luteinizing hormone-releasing hormone receptor type I (LH-RH-I) as a potential molecular target in OCM-1 and OCM-3 human uveal melanoma cell lines.Comparative cell biological study of in vitro antitumor and antimetastatic activity on melanoma cells of GnRH-III-containing conjugates modified with short-chain fatty acids
P2860
Q33629937-C5A1A200-6619-4632-B1CE-4074F50EFF1BQ33927508-388AA212-A4C6-430E-8C98-A47CA1157A6CQ34302297-CDA12D02-96E0-4E52-B0DF-ED16701975FFQ36236479-1EEC7782-3D4F-4C70-9D5F-75659A3F36BFQ36418891-A488FC6A-4AC1-41C3-B5C2-9435F1BC9B8CQ37381602-FB947357-01DF-4059-9CC8-8FA4D9D1B24CQ37641368-9769CE96-90CA-45CB-BB18-547F989202ACQ37724516-1263790F-4B7D-4BEE-9D1B-46E35FFDBBF1Q38882916-717A8090-2F3E-4080-ACF0-85913FCC9870Q39842559-0027C766-2EC8-4ECB-B616-BA37C82B82E3Q42117021-F2942A31-6B0E-4156-B0DF-4F78353211C3Q50350314-B7089195-2531-4744-99DF-75B9159C86E0Q57821212-E9BDC7D8-827D-4633-BA8D-D03B57C1A09C
P2860
Human malignant melanomas express receptors for luteinizing hormone releasing hormone allowing targeted therapy with cytotoxic luteinizing hormone releasing hormone analogue.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Human malignant melanomas expr ...... ne releasing hormone analogue.
@en
type
label
Human malignant melanomas expr ...... ne releasing hormone analogue.
@en
prefLabel
Human malignant melanomas expr ...... ne releasing hormone analogue.
@en
P2093
P50
P1433
P1476
Human malignant melanomas expr ...... one releasing hormone analogue
@en
P2093
Attila Nagy
Benjamin Baker
Gabriela Westphal
Gunhild Keller
Timo Gaiser
P304
P356
10.1158/0008-5472.CAN-04-3816
P407
P577
2005-07-01T00:00:00Z